Melatonin and mitochondrial function

Life Sciences

Volumn 75, Issue 7, 2004, Pages 765-790

  Leon, Josefa ^a   Acuña Castroviejo, Dario ^b   Sainz, Rosa M ^a   Mayo, Juan C ^a   Tan, Dun Xian ^a   Reiter, Russel J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Aging; Alzheimer's disease; Ischemia reperfusion; Melatonin; Mitochondria; Parkinson's disease; Reactive nitrogen species; Reactive oxygen species; Sepsis

Indexed keywords

ANTIOXIDANT; MELATONIN; NITROGEN; OXYGEN;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CELL DEATH; CELL FUNCTION; ELECTRON TRANSPORT; EPILEPSY; ISCHEMIA; MITOCHONDRION; MOLECULAR DYNAMICS; NECROSIS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; REPERFUSION; SEPSIS; SHORT SURVEY;

EID: 2942625711     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.03.003     Document Type: Review

References (217)

1. Absi E., Ayala A., Machado A., Parrado J. Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain. Journal of Pineal Research. 29(1):2000;40-47
2. Acuña-Castroviejo D., Pablos M.I., Menendez-Pelaez A., Reiter R.J. Melatonin receptors in purified cell nuclei of liver. Research Communications in Chemical Pathology and Pharmacology. 82(2):1993;253-256
3. Acuña-Castroviejo D., Reiter R.J., Menendez-Pelaez A., Pablos M.I., Burgos A. Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. Journal of Pineal Research. 16(2):1994;100-112
4. Acuña-Castroviejo D., Escames G., Macias M., Munoz-Hoyos A., Molina-Carballo A., Arauzo M., Montes R. Cell protective role of melatonin in the brain. Journal of Pineal Research. 19(2):1995;57-63
5. Acuña-Castroviejo D., Coto-Montes A., Gaia Monti M., Ortiz G.G., Reiter R.J. Melatonin is protective against MPTP-induced striatal and hippocampal lesions. Life Sciences. 60(2):1997;PL23-PL29
6. Acuña-Castroviejo D., Martin M., Macias M., Escames G., Leon J., Khaldy H., Reiter R.J. Melatonin, mitochondria, and cellular bioenergetics. Journal of Pineal Research. 30(2):2001;65-74
7. Acuña-Castroviejo D., Escames G., Carazo A., Leon J., Khaldy H., Reiter R.J. Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Current Topics in Medicinal Chemistry. 2(2):2002;133-151
8. Adams J.D. Jr., Klaidman L.K., Ribeiro P. Tyrosine hydroxylase: mechanisms of oxygen radical formation. Redox Reports. 3(5-6):1997;273-279
9. Allegra M., Reiter R.J., Tan D.X., Gentile C., Tesoriere L., Livrea M.A. The chemistry of melatonin's interaction with reactive species. Journal of Pineal Research. 34(1):2003;1-10
10. Antolin I., Rodriguez C., Sainz R.M., Mayo J.C., Uria H., Kotler M.L., Rodriguez-Colunga M.J., Tolivia D., Menendez-Pelaez A. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB Journal. 10(8):1996;882-890
11. Antolin I., Mayo J.C., Sainz R.M., del Brio M.L., Herrera F., Martin V., Rodriguez C. Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Research. 943(2):2002;163-173
12. Anton-Tay F., Ramirez G., Martinez I., Benitez-King G. In vitro stimulation of protein kinase C by melatonin. Neurochemical Research. 23(5):1998;601-606
13. Antunes F., Han D., Rettori D., Cadenas E. Mitochondrial damage by nitric oxide is potentiated by dopamine in PC12 cells. Biochimica et Biophysica Acta. 1556(2-3):2002;233-238
14. Banki K., Hutter E., Gonchoroff N.J., Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling. Journal of Immunology. 162(3):1999;1466-1479
15. Barja G. Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. Journal of Bioenergetics and Biomembranes. 31(4):1999;347-366
16. Barja G., Herrero A.J. Localization at complex I and mechanism of the higher free radical production of brain non synaptic mitochondria in the short-lived rat than in the longevous pigeon. Journal of Bioenergetics and Biomembranes. 30(3):1998;235-243
17. Behl C., Davis J.B., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid protein toxicity. Biochemical and Biophysics Research Communications. 186(2):1992;944-950
18. Benitez-King G., Huerto-Delgadillo L., Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sciences. 53(3):1993;201-207
19. Benot S., Goberna R., Reiter R.J., Garcia-Maurino S., Osuna C., Guerrero J.M. Physiological levels of melatonin contribute to the antioxidant capacity of human serum. Journal of Pineal Research. 27(1):1999;59-64
20. Bettahi I., Guerrero J.M., Reiter R.J., Osuna C. Physiological concentrations of melatonin inhibit the norepinephrine-induced activation of prostaglandin E2 and cyclic AMP production in rat hypothalamus: a mechanism involving inhibiton of nitric oxide synthase. Journal of Pineal Research. 25(1):1998;34-40
21. Bikjdaouene L., Escames G., Leon J., Ferrer J.M., Khaldy H., Vives F., Acuña-Castroviejo D. Changes in brain amino acids and nitric oxide after melatonin administration in rats with pentylenetetrazole-induced seizures. Journal of Pineal Research. 35(1):2003;54-60
22. Blask D.E., Sauer L.A., Dauchy R.T. Melatonin as a chronobiotic/ anticancer agent: cellular, biochemical, and molecular action and therapeutic implications for circadian-based cancer therapy. Current Topics in Medicinal Chemistry. 2(2):2002;113-132
23. Borutaite V., Morkuniene R., Brown G.C. Nitric oxide donors, nitrosothiols, and mitochondrial respiration inhibitors induce caspase activation by different mechanisms. FEBS Letters. 467(2-3):2000;155-159
24. Bossy-Wetzel E., Newmeyer D.D., Green D.R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO Journal. 17(1):1998;37-49
25. Brown G.C., Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radical in Biology and Medicine. 33(11):2002;1440-1450
26. Butler J., Jayson G.G., Swallow A.J. The reaction between the superoxide anion radical and cytochrome c. Biochimica et Biophysica Acta. 408(3):1975;215-222
27. 2. Journal Pineal Research. 34(2):2003;134-142
28. Cardinali D.P. Clinical perspectives for the use of melatonin as a neuroprotective chronobiotic in Alzheimer's disease. Akualnosci Neurologiczne. 3(3):2003;188-204
29. Carlberg C. Gene regulation by melatonin. Annals of the New York Academy of Sciences. 917(1):2000;387-396
30. Carlberg C., Hooft van Huijsduijnen R., Staple J.K., DeLamarter J.F., Becker-Andre M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Molecular Endocrinology. 8(6):1994;757-770
31. Cassarino D.S., Swerdlow R.H., Parks J.K., Parker W.D. Jr., Bennett J.P. Jr. Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids. Biochemical and Biophysic Research Communications. 248(1):1998;168-173
32. Cassina A., Radi R. Different inhibitory actions of NO and peroxynitrite on mitochondrial electron transport. Archives of Biophysics and Biochemistry. 328(2):1996;309-316
33. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiological Reviews. 59(3):1979;527-605
34. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: Central role of complex III. Journal of Biological Chemistry. 278(38):2003;36027-36031
35. Chernyak B.V. Redox regulation of the mitochondrial permeability transition pore. Bioscience Reports. 17(3):1997;293-302
36. Cleeter M.W., Cooper J.M., Darley-Usmar V.M., Moncada S., Schapira A.H. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Letters. 345(1):1994;50-54
37. Cooper J.M., Mann V.M., Schapira A.H. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. Journal of Neurological Sciences. 113(1):1992;91-98
38. Costa E.J., Shida C.S., Biaggi M.H., Ito A.S., Lamy-Freund M.T. How melatonin interacts with lipid bilayers: a study by fluorescence and ESR spectroscopies. FEBS Letters. 416(1):1997;103-106
39. Crespo E., Macias M., Pozo D., Escames G., Martin M., Vives F., Guerrero J.M., Acuña-Castroviejo D. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB Journal. 13(12):1999;1537-1546
40. Dabbeni-Sala F., Di Santo S., Franceschini D., Skaper S.D., Giusti P. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB Journal. 15(1):2001;164-170
41. Dabbeni-Sala F., Floreani M., Franceschini D., Skaper S.D., Giusti P. Kainic acid induces selective mitochondrial oxidative phosphorylation enzyme dysfunction in cerebellar granule neurons: protective effects of melatonin and GSH ethyl ester. FASEB Journal. 15(10):2001;1786-1788
42. de Atenor M.S., de Romero I.R., Brauckmann E., Pisano A., Legname A.H. Effects of the pineal gland and melatonin on the metabolism of oocytes in vitro and on ovulation in Bufo arenarum. Journal of Experimental Zoology. 268(6):1994;436-441
43. Dodel R.C., Du Y., Bales K.R., Ling Z.D., Carvey P.M., Paul S.M. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum- induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience. 86(3):1998;701-707
44. Doolen S., Krause D.N., Dubocovich M.L., Duckles S.P. Melatonin mediates two distinct responses in vascular smooth muscle. European Journal of Pharmacology. 345(1):1998;67-69
45. Dröge W. Free radicals in the physiological control of cell function. Physiological Reviews. 82(1):2002;47-95
46. Dubocovich M.L., Masana M.I., Iacob S., Sauri D.M. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn-Schmiedeberg's Archives of Pharmacology. 355(3):1997;365-375
47. Escames G., Leon J., Macias M., Khaldy H., Acuña-Castroviejo D. Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB Journal. 17(8):2003;932-934
48. Esteve J.M., Mompo J., Garcia de la Asuncion J., Sastre J., Asensi M., Boix J., Vina J.R., Vina J., Pallardo F.V. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro. FASEB Journal. 13(9):1999;1055-1064
49. Floreani M., Skaper S.D., Facci L., Lipartiti M., Giusti P. Melatonin maintains glutathione homeostasis in kainic acid-exposed rat brain tissues. FASEB Journal. 11(14):1997;1309-1315
50. Fosslien E. Mitochondrial medicine - molecular pathology of defective oxidative phosphorylation. Annals of Clinical Laboratory of Sciences. 31(1):2001;25-67
51. Fridovich I. Superoxide radical and superoxide dismutases. Annual Reviews of Biochemistry. 64(1):1995;97-112
52. Garcia J.J., Reiter R.J., Pie J., Ortiz G.G., Cabrera J., Sainz R.M., Acuña-Castroviejo D. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. Journal of Bioenergetics and Biomembranes. 31(6):1999;609-616
53. Gavazza M., Catala A. Melatonin preserves arachidonic and docosapentaenoic acids during ascorbate-Fe2+ peroxidation of rat testis microsomes and mitochondria. International Journal of Biochemistry and Cell Biology. 35(3):2003;359-366
54. Genova M.L., Ventura B., Giuliano G., Bovina C., Formiggini G., Parenti C.G., Lenaz G. The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2. FEBS Letters. 505(3):2001;364-368
55. Genova M.L., Pich M.M., Biondi A., Bernacchia A., Falasca A., Bovina C., Formiggini G., Castelli G.P., Lenaz G. Mitochondrial production of oxygen radical species and the role of coenzyme Q as an antioxidant. Experimental Biology and Medicine. 228(5):2003;506-513
56. Ghafourifar P., Richter C. Nitric oxide synthase activity in mitochondria. FEBS Letters. 418(3):1997;291-296
57. Ghafourifar P., Schenk U., Klein S.D., Richter C. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. Journal of Biological Chemistry. 274(74):1999;31185-31188
58. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysics Research Communications. 120(3):1984;885-890
59. Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochemical Journal. 332(Pt 3):1998;673-679
60. Giulivi C. Characterization and function of mitochondrial nitric-oxide synthase. Free Radicals in Biology and Medicine. 34(4):2003;397-408
61. Giulivi C., Poderoso J.J., Boveris A. Production of nitric oxide by mitochondria. Journal of Biological Chemistry. 273(18):1998;11038-11043
62. Giulivi C., Boveris A., Cadenas E. The steady state concentrations of oxygen radicals in mitochondria. Gilbert D.L., Colton C.A. Reactive oxygen species in biological systems. 1999;77-102 Plenum Publishers, New York
63. Guerrero J.M., Reiter R.J. Melatonin-immune system relationships. Current Topics in Medicinal Chemistry. 2(2):2002;167-179
64. Guidot D.M., Repine J.E., Kitlowski A.D., Flores S.C., Nelson S.K., Wright R.M., McCord J.M. Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism. Journal of Clinical Investigation. 96(2):1995;1131-1136
65. Halestrap A.P., McStay G.P., Clarke S.J. The permeability transition pore complex: another view. Biochimie. 84(2-3):2000;153-166
66. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. 2nd ed. 1989;Clarenden Press, London
67. Ham A.J., Liebler D.C. Vitamin E oxidation in rat liver mitochondria. Biochemistry. 34(17):1995;5754-5761
68. Han D., Williams E., Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochemical Journal. 353(Pt 2):2001;411-416
69. Han D., Antunes F., Canali R., Rettori D., Cadenas E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. Journal of Biological Chemistry. 278(8):2003;5557-5563
70. Han D., Canali R., Rettori D., Kaplowitz N. Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Molecular Pharmacology. 64(5):2003;1136-1144
71. Hara M., Yoshida M., Nishijima H., Yokosuka M., Iigo M., Ohtani-Kaneko R., Shimada A., Hasegawa T., Akama Y., Hirata K. Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats. Journal of Pineal Research. 30(3):2001;129-138
72. Hardeland R., Poeggeler B. Non-vertebrate melatonin. Journal of Pineal Research. 34(4):2003;233-241
73. Harman D. Aging: a theory based on free radical and radiation chemistry. Journal of Gerontology. 11(1):1956;298-300
74. Harman D. The aging process. Proceedings of the National Academy of Sciences U.S.A. 78(11):1981;7124-7128
75. Harper M.E., Monemdjou S., Ramsey J.J., Weindruch R. Age-related increase in mitochondrial proton leak and decrease in ATP turnover reactions in mouse hepatocytes. American Journal of Physiology. 275(2 Pt 1):1998;E197-E206
76. Hartmann A., Hunot S., Michel P.P., Muriel M.P., Vyas S., Faucheux B.A., Mouatt-Prigent A., Turmel H., Srinivasan A., Ruberg M., Evan G.I., Agid Y., Hirsch E.C. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proceedings of the National Academy of Sciences U.S.A. 97(6):2000;2875-2880
77. Hattori N., Tanaka M., Ozawa T., Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Annals of Neurology. 30(4):1991;563-571
78. Hirata F., Hayaishi O., Tokuyama T., Seno S. In vitro and in vivo formation of two new metabolites of melatonin. Journal of Biological Chemistry. 249(4):1974;1311-1313
79. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. Journal of Biological Chemistry. 275(34):2000;26096-26101
80. Jou M.J., Jou S.B., Chen H.M., Lin C.H., Peng T.I. Critical role of mitochondrial reactive oxygen species formation in visible laser irradiation-induced apoptosis in rat brain astrocytes (RBA-1). Journal of Biomedical Sciences. 9(6 Pt 1):2002;507-516
81. Kadenbach B. Intrinsic and extrinsic uncoupling of oxidative phosphorylation. Biochimica et Biophysica Acta. 1604(2):2003;77-94
82. Kadenbach B., Arnold S. A second mechanism of respiratory control. FEBS Letters. 447(2-3):1999;131-134
83. Kaptanoglu E., Tuncel M., Palaoglu S., Konan A., Demirpence E., Kilinc K. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. Journal of Neurosurgery. 93(1):2000;77-84
84. Karbownik M., Reiter R.J., Garcia J.J., Tan D.X., Qi W., Manchester L.C. Melatonin reduces rat hepatic macromolecular damage due to oxidative stress caused by delta-aminolevulinic acid. Biochimica et Biophysica Acta. 1523(2-3):2000;140-146
85. Karbownik M., Tan D., Manchester L.C., Reiter R.J. Renal toxicity of the carcinogen delta-aminolevulinic acid: antioxidant effects of melatonin. Cancer Letters. 161(1):2000;1-7
86. Khaldy H., Escames G., Leon J., Vives F., Luna J.D., Acuña- Castroviejo D. Comparative effects of melatonin, L-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro. Journal of Pineal Research. 29(2):2000;100-107
87. Khaldy H., Escames G., Leon J., Bikjdaouene L., Acuña-Castroviejo D. Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion. Neurobiology of Aging. 24(3):2003;491-500
88. Kilanczyk E., Bryszewska M. The effect of melatonin on antioxidant enzymes in human diabetic skin fibroblasts. Cellular and Molecular Biology Letters. 8(2):2003;333-336
89. Kim J.S., He L., Lemasters J.J. Mitochondrial permeability transition: A common pathway to necrosis and apoptosis. Biochemical and Biophysical Research Communications. 304(3):2003;463-470
90. Klotz L.O., Sies H. Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicology Letters. 140-141(1):2003;125-132
91. Korshunov S.S., Skulachev V.P., Strakov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Letters. 416(1):1997;15-18
92. Kroemer G., Petit P.X., Zamzami N., Vayssiere J.L., Mgnotte B. The biochemistry of programmed cell death. FASEB Journal. 9(4):1995;1277-1287
93. Kushnareva Y., Murphy A.N., Andreyev A. Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochemical Journal. 368(Pt 2):2002;545-553
94. Kwak C.S., Mun K.C., Suh S.I. Production of oxygen free radicals and of hemolysis by cyclosporine. Transplantation Proceedings. 34(7):2002;2654-2655
95. LeDoux S.P., Driggers W.J., Hollensworth B.S., Wilson G.L. Repair of alkylation and oxidative damage in mitochondrial DNA. Mutation Research. 434(3):1999;149-159
96. Lee I., Bender E., Arnold S., Kadenbach B. New control of mitochondrial membrane potential and ROS formation: a hypothesis. Journal of Biological Chemistry. 382(12):2001;1629-1636
97. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life. 52(3-5):2001;159-164
98. Leon J., Vives F., Crespo E., Camacho E., Espinosa A., Gallo M.A., Escames G., Acuña-Castroviejo D. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives. Journal of Neuroendocrinology. 10(4):1998;297-302
99. Leon J., Macias M., Escames G., Camacho E., Khaldy H., Martin M., Espinosa A., Gallo M.A., Acuña-Castroviejo D. Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines. Molecular Pharmacology. 58(5):2000;967-975
100. Leist M., Volbracht C., Fava E., Nicotera P. 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. Molecular Pharmacology. 54(5):1998;789-801
101. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J.A., Robinson J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. Journal of Biological Chemistry. 278(10):2003;8516-8525
102. Liu H., Kehrer J.P. The reduction of glutathione disulfide produced by t-butyl hydroperoxide in respiring mitochondria. Free Radicals in Biololgy and Medicine. 20(3):1996;433-442
103. 2-formyl-5-methoxykynuramine and 6-methoxymelatonin reduce oxidative DNA damage induced by Fenton reagents. Journal of Pineal Research. 34(3):2003;178-184
104. Ludwig B., Bender E., Arnold S., Hüttemann M., Lee I., Kadenbach B. Cytochrome c oxidase and the regulation of oxidative phosphorylation. ChemBioChem. 2(6):2001;392-403
105. Macias M., Rodriguez-Cabezas M.N., Reiter R.J., Osuna A., Acuña-Castroviejo D. Presence and effects of melatonin in Trypanosoma cruzi. Journal of Pineal Research. 27(2):1999;86-94
106. Maharaj D.S., Walker R.B., Glass B.D., Daya S. 6-Hydroxymelatonin protects against cyanide induced oxidative stress in rat brain homogenates. Journal of Chemical Neuroanatomy. 26(2):2003;103-107
107. Manchester L.C., Tan D.X., Reiter R.J., Park W., Monis K., Qi W. High levels of melatonin in the seeds of edible plants: possible function in germ tissue protection. Life Sciences. 67(25):2000;3023-3029
108. Mansouri A., Demeilliers C., Amsellem S., Pessayre D., Fromenty B. Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. Journal of Pharmacology and Experimental Therapeutics. 298(2):2001;737-743
109. Martin M., Macias M., Escames G., Leon J., Acuña-Castroviejo D. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl hydroperoxide-induced mitochondrial oxidative stress. FASEB Journal. 14(12):2000;1677-1679
110. Martin M., Macias M., Escames G., Reiter R.J., Agapito M.T., Ortiz G.G., Acuña-Castroviejo D. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. Journal of Pineal Research. 28(4):2000;242-248
111. Martin M., Macias M., Leon J., Escames G., Khaldy H., Acuña-Castroviejo D. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. International Journal of Biochemistry and Cell Biology. 34(4):2002;348-357
112. Matuszak Z., Reszka K., Chignell C.F. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radicals in Biology and Medicine. 23(3):1997;367-372
113. Maurer I., Zierz S., Moller H.J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiology of Aging. 21(3):2000;455-462
114. Maurizi C.P. Loss of intraventricular fluid melatonin can explain the neuropathology of Alzheimer's disease. Medical Hypotheses. 49(2):1997;153-158
115. Maurizi C.P. Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical and cerebrospinal fluid deficiency of melatonin. Medical Hypotheses. 57(2):2001;156-160
116. Mayo J.C., Sainz R.M., Uria H., Antolin I., Esteban M.M., Rodriguez C. Melatonin prevents apoptosis induced by 6-hydroxydopamine in neuronal cells: implications for Parkinson's disease. Journal of Pineal Research. 24(3):1998;179-192
117. McCann S.M. The nitric oxide hypothesis of brain aging. Experimental Gerontology. 32(4-5):1997;431-440
118. McKernan T.B., Woods E.B., Lash L.H. Uptake of glutathione by renal cortical mitochondria. Archives of Biochemistry and Biophysics. 288(2):1991;653-663
119. Menendez-Pelaez A., Reiter R.J. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. Journal of Pineal Research. 15(2):1993;59-69
120. Meyer-Rochow V.B., Vakkuri O. Head and abdominal melatonin in summer and winter bees. Journal of Pineal Research. 32(4):2002;275-276
121. Milczarek R., Klimek J., Zelewski L. Melatonin inhibits NADPH-dependent lipid peroxidation in human placental mitochondria. Hormones and Metabolism Research. 32(2):2000;84-85
122. Miquel J., Economos A.C., Fleming J., Johnson J.E. Jr. Mitochondrial role in cell aging. Experimental Gerontology. 15(6):1980;575-591
123. Mitchell P., Moyle J. Chemiosmotic hypothesis of oxidative phosphorilation. Nature. 213(72):1967;137-139
124. Mohanan P.V., Yamamoto H.A. Preventive effect of melatonin against brain mitochondria DNA damage, lipid peroxidation and seizures induced by kainic acid. Toxicology Letters. 129(1-2):2002;99-105
125. Molina-Carballo A., Muñoz-Hoyos A., Reiter R.J., Sanchez-Forte M., Moreno-Madrid F., Rufo-Campos M., Molina-Font J.A., Acuña-Castroviejo D. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience. Journal of Pineal Research. 23(2):1997;97-105
126. Morioka N., Okatani Y., Wakatsuki A. Melatonin protects against age-relatd DNA damage in the brains of female senescence-accelerated mice. Journal of Pineal Research. 27(3):1999;202-209
127. Moriya R., Uehara T., Momura Y. Mechanism of nitric oxide-induced apoptosis in human neuroblastoma SH-SY5Y cells. FEBS Letters. 484(3):2000;253-260
128. Murphy M.P. Nitric oxide and cell death. Biochimica et Biophysica Acta. 1411(2-3):1999;401-414
129. Nicholls D.G., Budd S.L. Mitochondria and neuronal survival. Physiological Reviews. 80(1):2000;315-360
130. Nicholls D.G., Ferguson S.J. Bioenergetics. vol. 2:1992;Academic Press, London
131. Nosjean O., Ferro M., Coge F., Beauverger P., Henlin J.M., Lefoulon F., Fauchere J.L., Delagrange P., Canet E., Boutin J.A. Identification of the melatonin-binding site MT3 as the quinone reductase 2. Journal of Biological Chemistry. 275(40):2000;31311-31317
132. Okado-Matsumoto A., Fridovich I. Assay of superoxide dismutase: cautions relevant to the use of cytochrome c, a sulfonated tetrazolium, and cyanide. Analytical Biochemistry. 298(2):2001;337-342
133. Okatani Y., Wakatsuki A., Reiter R.J. Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice. Journal of Pineal Research. 32(3):2002;143-148
134. Okatani Y., Wakatsuki A., Reiter R.J., Miyahara Y. Hepatic mitochondrial dysfunction in senescence-accelerated mice: correction by long-term, orally administered physiological levels of melatonin. Journal of Pineal Research. 33(3):2002;127-133
135. Okatani Y., Wakatsuki A., Reiter R.J., Miyahara Y. Acutely administered melatonin restores hepatic mitochondrial physiology in old mice. International Journal of Biochemistry and Cell Biology. 35(3):2003;367-375
136. Okatani Y., Wakatsuki A., Enzan H., Miyahara Y. Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver. European Journal of Pharmacology. 469(1-3):2003;145-152
137. Ortiz G.G., Crespo-Lopez M.E., Moran-Moguel C., Garcia J.J., Reiter R.J., Acuña-Castroviejo D. Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo. Neuroendocrinology Letters. 22(2):2001;101-108
138. Othman A.I., El-Missiry M.A., Amer M.A. The protective action of melatonin on indomethacin-induced gastric and testicular oxidative stress in rats. Redox Reports. 6(3):2001;173-177
139. Pablos M.I., Reiter R.J., Ortiz G.G., Guerrero J.M., Agapito M.T., Chuang J.I., Sewerynek E. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochemistry International. 32(1):1998;69-75
140. Papa S., Guerrieri F., Capitanio N. A possible role of slips in cytochrome c oxidase in the antioxygen defense system of the cell. Bioscience Reports. 17(1):1997;23-31
141. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. Journal of Neuroscience. 17(5):1997;1683-1690
142. Pappolla M.A., Chyan Y.J., Poeggeler B., Bozner P., Ghiso J., LeDoux S.P., Wilson G.L. Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. Journal of Pineal Research. 27(4):1999;226-229
143. Pappolla M.A., Chyan Y.J., Poeggeler B., Frangione B., Wilson G., Ghiso J., Reiter R.J. An assessment of the antioxidant and antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. Journal of Neural Transmission. 107(2):2000;203-231
144. Phung C.D., Ezieme J.A., Turrens J.F. Hydrogen peroxide metabolism in skeletal muscle mitochondria. Archives of Biochemistry and Biophysics. 315(2):1994;479-482
145. Poon A.M., Pang S.F. 2[125I]Iodomelatonin binding sites in spleens of guinea pigs. Life Sciences. 50(22):1992;1719-1726
146. Pozo D., Reiter R.J., Calvo J.R., Guerrero J.M. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sciences. 55(24):1994;PL455-PL460
147. Prunet-Marcassus B., Ambid L., Viguerie-Bascands N., Penicaud L., Casteilla L. Evidence for a direct effect of melatonin on mitochondrial genome expression of Siberian hamster brown adipocytes. Journal of Pineal Research. 30(2):2001;108-115
148. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. American Journal of Physiology (Lung Cellular and Molecular Physiolology 12). 268(5 Pt 1):1995;L699-L722
149. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, disease and ageing. Trends in Biochemical Sciences. 25(10):2000;502-508
150. Reiter R.J. The pineal and its hormones in the control of reproduction in mammals. Endocrine Reviews. 1(2):1980;109-131
151. Reiter R.J. Melatonin: The chemical expression of darkness. Molecular and Cellular Endocrinology. 79(1-3):1991;C153-C158
152. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Reviews. 12(2):1991;151-180
153. Reiter R.J. The ageing pineal gland and its physiological consequences. Bioessays. 14(3):1992;169-175
154. Reiter R.J. Melatonin: clinical relevance. Best Practice and Research Clinical Endocrinology and Metabolism. 17(2):2003;273-285
155. Reiter R.J., Tan D.X. Melatonin: an antioxidant in edible plants. Annals of the New York Academy of Sciences. 957(1):2002;341-344
156. Reiter R.J., Tan D.X. What constitutes a physiological concentration of melatonin? Journal of Pineal Research. 34(1):2003;79-80
157. Reiter R.J., Tan D.X., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. Journal of Biomedical Science. 7(3):2000;444-458
158. Reiter R.J., Tan D.X., Burkhardt S., Manchester L.C. Melatonin in plants. Nutrition Reviews. 59(9):2001;286-290
159. Reiter R.J., Tan D.X., Manchester L.C., El-Sawi M.R. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Annals of the New York Academy of Sciences. 959(1):2002;238-250
160. Reppert S.M., Weaver D.R., Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron. 13(5):1994;1177-1185
161. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Procedings of the National Academic Sciences, U.S.A. 92(19):1995;8734-8738
162. Reyes-Toso C.F., Ricci C.R., De Mignone I.R., Reyes P., Linares L.M., Albornoz L.E., Cardinali D.P., Zaninovich A. In vitro effect of melatonin on oxygen consumption in liver mitochondria of rats. Neuroendocrinology Letters. 24(5):2003;341-344
163. Richte C. Do mitochondrial DNA fragments promote cancer and aging? FEBS Letters. 241(1-2):1988;1-5
164. Robakis N.K. Amyloid and amyloid precursor protein: chemistry, molecular biology, and neuropathology. Terry R.D., Katzman R., Bick K.L. Alzheimer disease. 1994;317-326 Raven, New York
165. Rodriguez C., Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., Reiter R.J. Regulation of antioxidant enzymes: a significant role for melatonin. Journal of Pineal Research. 36(2):2004;1-9
166. Rodriguez-Reynoso S., Leal C., Portilla E., Olivares N., Muniz J. Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-alpha and nitric oxide. Journal of Surgery Research. 100(2):2001;141-149
167. 2-formyl-5- methoxykynuramine is a product of melatonin oxidation in rats. Journal of Pineal Research. 35(4):2004;245-259
168. Rubbo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. Journal of Biological Chemistry. 269(42):1994;26066-26075
169. Sainz R.M., Mayo J.C., Rodriguez C., Tan D.X., Lopez-Burillo S., Reiter R.J. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cellular and Molecular Life Sciences. 60(7):2003;1407-1426
170. Sarkela T.M., Berthiaume J., Elfering S., Gybina A.A., Giulivi C. The modulation of oxygen radical production by nitric oxide in mitochondria. Journal of Biological Chemistry. 276(10):2001;6945-6949
171. Sato N., Iwata S., Kakamura K., Hori T., Mori K., Yodoi J. Thiol-mediated redox regulation of apoptosis. Possible roles of cellular thiols other than gluthatione in T cell apoptosis. Journal of Immunology. 154(7):1995;3194-3203
172. Schapira A.H., Cooper J.M., Dexter D., Jenner P., Clark J.B., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1(8649):1989;1269
173. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO Journal. 12(8):1993;3095-3104
174. Scott A.E., Cosma G.N., Frank A.A., Wells R.L., Gardner H.S. Jr. Disruption of mitochondrial respiration by melatonin in MCF-7 cells. Toxicology and Applied Pharmacology. 171(3):2001;149-156
175. Seyfried J., Soldner F., Kunz W.S., Schulz J.B., Klockgether T., Kovar K.A., Wullner U. Effect of 1-methyl-4-phenylpyridinium on glutathione in rat pheochromocytoma PC 12 cells. Neurochemistry International. 36(6):2000;489-497
176. Sewerynek E., Wiktorska J., Lewinski A. Effects of melatonin on the oxidative stress induced by thyrotoxicosis in rats. Neuroendocrinology Letters. 20(3-4):1999;157-161
177. Sharman E.H., Bondy S.C. Effects of age and dietary antioxidants on cerebral electron transport chain activity. Neurobiology of Aging. 22(4):2001;629-634
178. Shults C.W., Haas R.H., Passov D., Beal M.F. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Annals of Neurology. 42(2):1997;261-264
179. Siles E., Martinez-Lara E., Canuelo A., Sanchez M., Hernandez R., Lopez-Ramos J.C., Del Moral M.L., Esteban F.J., Blanco S., Pedrosa J.A., Rodrigo J., Peinado M.A. Age-related changes of the nitric oxide system in the rat brain. Brain Research. 956(2):2002;385-392
180. Simon N., Papa K., Vidal J., Boulamery A., Bruguerolle B. Circadian rhythms of oxidative phosphorylation: effects of rotenone and melatonin on isolated rat brain mitochondria. Chronobiology International. 20(3):2003;451-461
181. Sohal R.S., Dubey A. Mitochondrial oxidative damage, hydrogen peroxide release, and aging. Free Radicals in Biology and Medicine. 16(5):1994;621-626
182. Stadler J., Stefanovic-Racic M., Billiar T.R., Curran R.D., McIntyre L.A., Georgescu H.I., Simmons R.L., Evans C.H. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. Journal of Immunology. 147(11):1991;3915-3920
183. Stadler J., Bentz B.G., Harbrecht B.G., Di Silvio M., Curran R.D., Billiar T.R., Hoffman R.A., Simmons R.L. Tumor necrosis factor alpha inhibits hepatocyte mitochondrial respiration. Annals of Surgery. 216(5):1992;539-546
184. Stadtman E.R., Levine R.L. Protein oxidation. Annals of the New York Academy of Sciences. 899(1):2000;191-208
185. Stamler J.S., Singel D.J., Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258(5090):1992;1898-1902
186. Strolin Benedetti M., Dostert P. Monoamine oxidase, brain aging and degenerative diseases. Biochemical Pharmacology. 38(4):1989;555-561
187. Szalai G., Krishnamurthy R., Hajnoczky G. Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO Journal. 18(22):1999;6349-6361
188. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocrine Journal. 1(1):1993;57-60
189. Tan D.X., Poeggeler B., Reiter R.J., Chen L.D., Chen S., Manchester L.C., Barlow-Walden L.R. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Letters. 70(1-2):1993;65-71
190. Tan D.X., Manchester L.C., Reiter R.J., Plummer B.F., Hardies L.J., Weintraub S.T., Vijayalaxmi, Shepherd A.M. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochemical and Biophysics Research Communications. 253(3):1998;614-620
191. Tan D.X., Manchester L.C., Reiter R.J., Plummer B.F., Limson J., Weintraub S.T., Qi W. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radicals in Biology and Medicine. 29(11):2000;1177-1185
192. Tan D.X., Manchester L.C., Burkhardt S., Sainz R.M., Mayo J.C., Kohen R., Shohami E., Huo Y.S., Hardeland R., Reiter R.J. N1-acetyl-N2-formyl-5- methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB Journal. 15(12):2001;2294-2296
193. Tan D.X., Hardeland R., Manchester L.C., Poeggeler B., Lopez-Burillo S., Mayo J.C., Sainz R.M., Reiter R.J. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. Journal of Pineal Research. 34(4):2003;249-259
194. Tan D.X., Manchester L.C., Hardeland R., Lopez-Burillo S., Mayo J.C., Sainz R.M., Reiter R.J. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. Journal of Pineal Research. 34(1):2003;75-78
195. Tilden A.R., Becker M.A., Amma L.L., Arciniega J., McGaw A.K. Melatonin production in an aerobic photosynthetic bacterium: an evolutionarily early association with darkness. Journal of Pineal Research. 22(2):1997;102-106
196. Trumpower B.L. Subunit 6 regulates half-of-the-sites reactivity of the dimeric cytochrome bc1 complex in Saccharomyces cerevisiae. Journal of Biological Chemistry. 265(28):1990;11409-11412
197. Turrens J.F., Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochemical Journal. 191(2):1980;421-427
198. Turrens J.F., Freeman B.A., Levitt J.G., Crapo J.D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Archives of Biochemistry and Biophysics. 217(2):1982;401-410
199. Urata Y., Honma S., Goto S., Todoroki S., Iida T., Cho S., Honma K., Kondo T. Melatonin induces gamma-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells. Free Radicals in Biology and Medicine. 27(7-8):1999;838-847
200. Ursini F., Heim S., Kiess M., Maiorino M., Roveri A., Wissing J., Flohe L. Dual function of the selenoprotein PHGPx during sperm maturation. Science. 285(5432):1999;1393-1396
201. Virmani A., Gaetani F., Imam S., Binienda Z., Ali S. The protective role of L-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Annals of the New York Academy of Sciences. 965(1):2002;225-232
202. Virmani A., Gaetani F., Imam S., Binienda Z., Ali S. Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. Annals of the New York Academy of Sciences. 993(1):2003;197-207
203. Vivien-Roels B., Pevet P. Melatonin: presence and formation in invertebrates. Experientia. 49(1):1993;642-647
204. Wakatsuki A., Okatani Y., Shinohara K., Ikenoue N., Fukaya T. Melatonin protects against ischemia/reperfusion-induced oxidative damage to mitochondria in fetal rat brain. Journal of Pineal Research. 31(2):2001;167-172
205. Wakatsuki A., Okatani Y., Shinohara K., Ikenoue N., Kaneda C., Fukaya T. Melatonin protects fetal rat brain against oxidative mitochondrial damage. Journal of Pineal Research. 30(1):2001;22-28
206. Wei Y.H., Lee H.C. Mitochondrial DNA mutations and oxidative stress in mitochondrial diseases. Advances in Clinical Chemistry. 37(1):2003;83-128
207. Wiesenberg I., Missbach M., Kahlen J.P., Schrader M., Carlberg C. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Research. 23(3):1995;327-333
208. Witt-Enderby P.A., Bennett J., Jarzynka M.J., Firestine S., Melan M.A. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sciences. 72(20):2003;2183-2198
209. Xu M., Ashraf M. Melatonin protection against lethal myocyte injury induced by doxorubicin as reflected by effects on mitochondrial membrane potential. Journal of Molecular and Cellular Cardiology. 34(1):2002;75-79
210. Yabuki M., Tsutsui K., Horton A.A., Yoshioka T., Utsumi K. Caspase activation and cytochrome c release during HL-60 cell apoptosis induced by a nitric oxide donor. Free Radical Research. 32(6):2000;507-514
211. Yamamoto H.A., Mohanan P.V. Melatonin attenuates brain mitochondria DNA damage induced by potassium cyanide in vivo and in vitro. Toxicology. 179(1-2):2002;29-36
212. Yamamoto H.A., Mohanan P.V. Ganglioside GT1B and melatonin inhibit brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Brain Research. 964(1):2003;100-106
213. Yuan H., Pang S.F. [125I]Iodomelatonin-binding sites in the pigeon brain: binding characteristics, regional distribution and diurnal variation. Journal of Endocrinology. 128(3):1991;475-482
214. Zamzami N., Kroemer G. The mitochondrion in apoptosis: how Pandora's Box opens. Nature Reviews in Molecular and Cellular Biology. 2(1):2001;67-71
215. Zatta P., Tognon G., Carampin P. Melatonin prevents free radical formation due to the interaction between β-amyloid peptides and metal ions [Al (III), Zn (II), Cu (II), Fe (II)]. Journal of Pineal Research. 35(2):2003;98-103
216. Zhang Y., Dawson V.L., Dawson T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiology of Disease. 7(4):2000;240-250
217. Zigmond M.J., Stricker E.M. Animal models of parkinsonism using selective neurotoxins: clinical and basic implications. International Review in Neurobiology. 31(1):1989;1-79